{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib7dx377x7yjztvewj3vhdk5h5hhdl7deuiradzbz4kjt2qvri344",
    "uri": "at://did:plc:2gbt2dlwaqovtnmxkat3tyke/app.bsky.feed.post/3mk2sf5cfulu2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreia7wu3fx3jpcoamjbksafxyolkotre4mffnwb43gq4ydtmj6ejjnm"
    },
    "mimeType": "image/jpeg",
    "size": 156596
  },
  "path": "/articles/d41586-026-01286-1",
  "publishedAt": "2026-04-22T05:48:52.777Z",
  "site": "https://www.nature.com",
  "tags": [
    "doi:10.1038/d41586-026-01286-1"
  ],
  "textContent": "Nature, Published online: 21 April 2026; doi:10.1038/d41586-026-01286-1\n\nSome researchers are delighted at an executive order to streamline investigations of psychedelics but also warn that caution is needed.",
  "title": "US speeds research into mind-altering drugs — including mysterious 'ibogaine'",
  "updatedAt": "2026-04-21T00:00:00.000Z"
}